Opinion: Pharma leaders: support the social contract on drug prices
I believe in the social contract that drug companies, mine included, have a duty to responsibly set drug prices so patients can access needed medicines.
by Paul Hastings
Jul 30, 2019
4 minutes
When I was 13 years old, my doctor told me I had Crohn’s disease, a painful gastrointestinal condition that swells the intestines and threatens the digestive tract. Breakthrough treatments like Remicade, Enbrel, and Humira were still decades away, so the diagnosis cost me my colon.
My surgeries and the lifelong challenges — and triumphs — that came with them inform my vantage point in the simmering drug pricing debate. I believe in the social contract that drug companies, mine included, have a duty to responsibly set list prices so patients can access needed medicines. And I think it’s time for industry leaders to exert more pressure on colleagues who
You’re reading a preview, subscribe to read more.
Start your free 30 days